By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Therapeutic Solutions International, Inc.

Therapeutic Solutions International, Inc. (TSOI)

OTC Currency in USD
$0.00
$0.00
0.00%
Last Update: 29 Aug 2025, 00:00
$512.27K
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.00
52 Week Range

TSOI Stock Price Chart

Explore Therapeutic Solutions International, Inc. interactive price chart. Choose custom timeframes to analyze TSOI price movements and trends.

TSOI Company Profile

Discover essential business fundamentals and corporate details for Therapeutic Solutions International, Inc. (TSOI) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

24 Jun 2008

Employees

3.00

CEO

Timothy George Dixon

Description

Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, traumatic brain injury, and lung pathologies, as well as for daily health. Its flagship products include QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production. The company also produces nutraceuticals, including ProJuvenol, a synergistic blend of complex anti-aging ingredients in capsules; NanoStilbene, a nanoemulsion of nanoparticle pterostilbene; DermalStilbene, a topical form of pterostilbene delivered through spray application onto skin; IsoStilbene, an injectable formulation of pterostilbene; NeuroStilbene, an intranasal form of pterostilbene; NanoPlus, a blend of NanoStilbene and Nano Cannabidiol; Nano Cannabidiol, a nanoparticle formulation of cannabidiol; NanoPSA, a blend of NanoStilbene and broccoli sprout extract; and NLRP3 Trifecta, a two-product combo that consists of one bottle of NanoPSA and one bottle of GTE-50 green tea extract. It is also developing therapeutics in chronic traumatic encephalopathy, and traumatic brain injury and lung pathology. Therapeutic Solutions International, Inc. was founded in 2007 and is based in Elk City, Idaho.

TSOI Financial Timeline

Browse a chronological timeline of Therapeutic Solutions International, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 18 Nov 2025

Earnings released on 20 Jun 2025

Earnings released on 29 May 2025

Earnings released on 22 Nov 2024

EPS came in at -$0.00 , while revenue for the quarter reached $19.67M .

Earnings released on 19 Aug 2024

EPS came in at -$0.00 , while revenue for the quarter reached $20.01K .

Earnings released on 30 May 2024

EPS came in at -$0.15 , while revenue for the quarter reached $21.81M .

Earnings released on 17 Apr 2024

EPS came in at -$0.00 , while revenue for the quarter reached $23.83K .

Earnings released on 14 Nov 2023

EPS came in at -$0.18 , while revenue for the quarter reached $25.73M .

Earnings released on 21 Aug 2023

EPS came in at -$0.00 , while revenue for the quarter reached $26.31K .

Earnings released on 16 May 2023

EPS came in at -$0.10 , while revenue for the quarter reached $23.12K .

Earnings released on 29 Mar 2023

EPS came in at -$0.00 , while revenue for the quarter reached $8.58K .

Earnings released on 17 Nov 2022

EPS came in at -$0.00 , while revenue for the quarter reached $74.54K .

Earnings released on 19 Aug 2022

EPS came in at -$0.00 , while revenue for the quarter reached $38.75K .

Earnings released on 23 May 2022

EPS came in at -$0.00 , while revenue for the quarter reached $84.90K .

Earnings released on 31 Mar 2022

EPS came in at -$0.00 , while revenue for the quarter reached $44.16K .

Earnings released on 22 Nov 2021

EPS came in at -$0.00 , while revenue for the quarter reached $57.29K .

Earnings released on 13 Aug 2021

EPS came in at -$0.00 , while revenue for the quarter reached $23.44K .

Earnings released on 17 May 2021

EPS came in at -$0.00 , while revenue for the quarter reached $21.06K .

Earnings released on 9 Apr 2021

EPS came in at -$0.00 , while revenue for the quarter reached $17.80K .

Earnings released on 19 Nov 2020

EPS came in at -$0.00 , while revenue for the quarter reached $11.35K .

TSOI Stock Performance

Access detailed TSOI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run